Deccan Health Care Ltd
Incorporated in 1996, Deccan Healthcare Ltd is a manufacturer of Fast moving consumer health products[1]
- Market Cap ₹ 61.3 Cr.
- Current Price ₹ 28.1
- High / Low ₹ 39.1 / 20.5
- Stock P/E 39.6
- Book Value ₹ 47.3
- Dividend Yield 0.00 %
- ROCE 2.55 %
- ROE 1.68 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.59 times its book value
- Debtor days have improved from 99.6 to 60.4 days.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 19.0%
- Company has a low return on equity of 1.68% over last 3 years.
- Promoter holding has decreased over last 3 years: -15.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Food - Processing - Indian
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
42.24 | 33.78 | 33.17 | 45.02 | 59.73 | 65.19 | |
30.57 | 31.74 | 27.54 | 43.06 | 55.97 | 61.31 | |
Operating Profit | 11.67 | 2.04 | 5.63 | 1.96 | 3.76 | 3.88 |
OPM % | 27.63% | 6.04% | 16.97% | 4.35% | 6.29% | 5.95% |
0.06 | 0.06 | -3.46 | 0.02 | 0.01 | 0.01 | |
Interest | 0.18 | 0.11 | 0.15 | 0.11 | 0.09 | 0.11 |
Depreciation | 1.42 | 1.47 | 1.47 | 1.43 | 1.47 | 1.49 |
Profit before tax | 10.13 | 0.52 | 0.55 | 0.44 | 2.21 | 2.29 |
Tax % | 0.39% | 25.00% | 40.00% | 31.82% | 33.03% | |
10.09 | 0.39 | 0.32 | 0.31 | 1.49 | 1.55 | |
EPS in Rs | 6.42 | 0.25 | 0.20 | 0.18 | 0.73 | 0.75 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 21% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 56% |
TTM: | 138% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | -19% |
3 Years: | -2% |
1 Year: | -3% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 2% |
Last Year: | 2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|
Equity Capital | 15.71 | 15.71 | 17.04 | 20.38 | 20.98 |
Reserves | 60.91 | 61.23 | 64.52 | 75.19 | 78.18 |
1.03 | 1.25 | 1.61 | 1.90 | 1.27 | |
14.61 | 12.44 | 13.62 | 10.58 | 12.75 | |
Total Liabilities | 92.26 | 90.63 | 96.79 | 108.05 | 113.18 |
19.87 | 18.53 | 16.85 | 15.69 | 15.04 | |
CWIP | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
72.32 | 72.10 | 79.94 | 92.36 | 98.14 | |
Total Assets | 92.26 | 90.63 | 96.79 | 108.05 | 113.18 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
2.68 | 0.22 | -0.57 | -6.76 | -12.55 | |
-1.94 | -0.07 | -0.05 | 0.27 | -0.30 | |
-1.77 | -0.37 | 0.07 | 5.26 | 14.04 | |
Net Cash Flow | -1.03 | -0.22 | -0.56 | -1.23 | 1.19 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 134.74 | 141.07 | 97.21 | 60.44 | |
Inventory Days | 890.81 | 1,182.75 | 683.64 | 445.05 | |
Days Payable | 112.09 | 147.78 | 123.28 | 41.68 | |
Cash Conversion Cycle | 913.46 | 1,176.04 | 657.58 | 463.81 | |
Working Capital Days | 545.99 | 603.01 | 509.48 | 478.54 | |
ROCE % | 5.62% | 0.68% | 2.55% |
Documents
Announcements
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18 Nov - Disclosure of substantial acquisition of shares in Deccan Health Care.
-
Disclosure Under Regulation 7(2) Of SEBI (PIT) Regulations, 2015
16 Nov - Disclosure under SEBI regulations regarding insider trading.
-
Intimation Of Application Filed With BSE For Approval Of Promoter Reclassification
15 Nov - Application for reclassification of promoter group to public category.
- Announcement under Regulation 30 (LODR)-Investor Presentation 15 Nov
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
15 Nov - Deccan Health Care reports strong Q2 FY25 financial results.
Business Overview:[1]
DHL is a Nutraceutical and wellness product company. Its food pills and meals are categorized under Fast Moving Consumer Healthcare (FMCH) products and covers 52 consumer wellness goals preventing over 200 diseases, disorders and disabilities due to micro nutritional deficiency. Company does sales of its Be Young brand through e-commerce platform www.beyoungstore.com